Trump administration moves to suspend national EV charger rollout
The bid to freeze the money upends how the federal government delivers funding to states and may violate court orders issued this week.
Related Articles
Increasing Breast Cancer Screening in Women Experiencing Homelessness
As part of its outreach to medically insecure individuals in Northeast Ohio, Cleveland Clinic Cancer Institute began a mobile mammography program that combines onsite mammography…
Novel Neoadjuvant Treatment Trial for Uveal Melanoma
Oral medication may have potential to preserve vision and shrink tumors prior to surgery or radiation
Home
February 18, 2025 // 1:00 PM – 4:00 PM CST Discover the latest advancements revolutionizing cancer treatment. We’ll explore breakthroughs in personalized medicine, immunotherapy, and…
Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia
Key PointsDasatinib, asciminib, and prednisone can be safely combined for the dual targeting of BCR::ABL1 in Ph+ acute leukemia.Dasatinib and asciminib com
Uterine cancer has been impacting more Black women: Here’s what to look out for
One especially frightening type of cancer that is extremely difficult to detect and seems to show up more often in Black women, affecting them even…
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update – PubMed
HDR monotherapy delivered in two fractions of 13.5 Gy demonstrated a persistent cancer control rate at 8 years and was well-tolerated. Single-fraction monotherapy yielded poor…
Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis
All investigated ablative methods continue to represent effective treatment choices in renal cell carcinoma, and these findings support multi-disciplinary discussions of these treatment methods, along…
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Background Pembrolizumab monotherapy is an established front-line treatment for advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) tumor proportion score (TPS)≥50%.…
Deimplementation Strategy to Reduce Low-Value Preoperative Testing
This quality improvement study investigates if a multicomponent deimplementation strategy directed at clinicians is associated with a reduction in low-value testing before general surgery operations.
